Boniva Roche and GlaxoSmithKline (GSK) - Treatment for Postmenopausal Osteoporosis

Boniva 150 mg is a bisphosphonate taken once-monthly for the treatment of postmenopausal osteoporosis. Patients take 12 tablets a year versus 52 required with current weekly bisphosphonate treatments.

Related Articles:

New Drug Application Submitted to FDA for Intravenous Injection of Boniva - December 8, 2004

Boniva Hoffmann-La Roche Inc - Treatment for Osteoporosis - May 16, 2003

Latest FDA Drug Approvals...

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals